Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN116730993A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116730993A reveals a novel Ir-catalyzed route for Teranavir. Achieve high-purity HIV protease inhibitors with reduced steps and cost reduction in API manufacturing.